MORE than 630 Aussies are dying from
liver failure caused by hepatitis C each year but a government
committee has rejected an $84,000 treatment that could cure them.
And it’s possible the residents of Fiji could access the breakthrough drug before Australian patients.
Breakthrough drug Sovaldi
could see the scourge of hepatitis C – currently afflicting 230,000
Australians – eventually wiped out because it cures the disease and
prevents it from being passed on.
Around a third of those on the
nation’s liver transplant waiting list have hepatitis C and the
treatment would free up those organs for others.